Previous studies indicated that NSCLC patients’ gut–lung microbiome composition varies according to aging; smoking; COPD; the histological type, stage, and grade of lung cancer; and the PD-L1 expression levels on tumor cells [16,32,40]. The gene discussed is CD274; the disease is neoplasm.